Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Ryan

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Drug Safety|May 5, 2019
Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims DataJenna M Reps, Peter R Rijnbeek, Patrick B Ryan
Plos One|February 14, 2020
Wisdom of the CROUD:  Development and validation of a patient-level prediction model for opioid use disorder using population-level claims dataJenna Marie Reps, M Soledad Cepeda, Patrick B Ryan
Diagnostic and Prognostic Research|April 17, 2025
Can we develop real-world prognostic models using observational healthcare data? Large-scale experiment to investigate model sensitivity to database and phenotypesJenna M Reps, Peter R Rijnbeek, Patrick B Ryan
Journal of Biomedical Informatics|August 7, 2019
Supplementing claims data analysis using self-reported data to develop a probabilistic phenotype model for current smoking statusJenna M Reps, Peter R Rijnbeek, Patrick B Ryan
AMIA ... Annual Symposium Proceedings. AMIA Symposium|December 24, 2011
Design and validation of a data simulation model for longitudinal healthcare dataRichard E Murray, Patrick B Ryan, Stephanie J Reisinger
Drug Safety|October 30, 2013
The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis systemChristian G Reich, Patrick B Ryan, Marc A Suchard
Drug Safety|October 30, 2013
Alternative outcome definitions and their effect on the performance of methods for observational outcome studiesChristian G Reich, Patrick B Ryan, Martijn J Schuemie
Health Services & Outcomes Research Methodology|February 12, 2013
Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposureFrank J Defalco, Patrick B Ryan, M Soledad Cepeda
Journal of Biomedical Informatics|August 22, 2022
PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluationJoel N Swerdel, Martijn Schuemie, Gayle Murray, et al.
Journal of Biomedical Informatics|June 12, 2012
Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databasesChristian Reich, Patrick B Ryan, Paul E Stang, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Drug Safety|May 5, 2019
Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims DataJenna M Reps, Peter R Rijnbeek, Patrick B Ryan
Plos One|February 14, 2020
Wisdom of the CROUD:  Development and validation of a patient-level prediction model for opioid use disorder using population-level claims dataJenna Marie Reps, M Soledad Cepeda, Patrick B Ryan
Diagnostic and Prognostic Research|April 17, 2025
Can we develop real-world prognostic models using observational healthcare data? Large-scale experiment to investigate model sensitivity to database and phenotypesJenna M Reps, Peter R Rijnbeek, Patrick B Ryan
Journal of Biomedical Informatics|August 7, 2019
Supplementing claims data analysis using self-reported data to develop a probabilistic phenotype model for current smoking statusJenna M Reps, Peter R Rijnbeek, Patrick B Ryan
AMIA ... Annual Symposium Proceedings. AMIA Symposium|December 24, 2011
Design and validation of a data simulation model for longitudinal healthcare dataRichard E Murray, Patrick B Ryan, Stephanie J Reisinger
Drug Safety|October 30, 2013
The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis systemChristian G Reich, Patrick B Ryan, Marc A Suchard
Drug Safety|October 30, 2013
Alternative outcome definitions and their effect on the performance of methods for observational outcome studiesChristian G Reich, Patrick B Ryan, Martijn J Schuemie
Health Services & Outcomes Research Methodology|February 12, 2013
Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposureFrank J Defalco, Patrick B Ryan, M Soledad Cepeda
Journal of Biomedical Informatics|August 22, 2022
PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluationJoel N Swerdel, Martijn Schuemie, Gayle Murray, et al.
Journal of Biomedical Informatics|June 12, 2012
Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databasesChristian Reich, Patrick B Ryan, Paul E Stang, et al.
Pageof 17